Generex Biotechnology Corp. (QB)
Ticker Symbol: USOTC:GNBT
OTC Market Tier: OTCQB
CIK Number: 0001059784
Security Type: Common Stock
GNBT Address: 10101 USA Today Way
Miramar, Florida 33025
GNBT Country: USA
GNBT Phone: (416) 364-2551
GNBT Fax #: 416-364-9363
Website: http://www.generex.com
Description: Generex Biotechnology is an integrated healthcare holding company with end-to-end solutions for patient centric care from rapid diagnosis through delivery of personalized therapies. Generex is building a new kind of healthcare company that extends beyond traditional models providing support to physicians in an MSO network, and ongoing relationships with patients to improve the patient experience and access to optimal care. In addition to advancing a legacy portfolio of immune-oncology assets, medical devices, and diagnostics, the Company is focused on an acquisition strategy of strategic businesses that complement existing assets and provide immediate sources of revenue and working capital. Recent acquisitions include a management services organization, a network of pharmacies, clinical laboratory, and medical device companies with new and approved products. Our newly formed, wholly-owned subsidiary, NuGenerex Distribution Solutions (NDS), integrates our MSO network with a pharmacy network, clinical diagnostic lab, durable medical equipment company (DME-IQ) and dedicated call center.
SIC Code / Description: 2834 / Pharmaceutical preparations
Shares Authorized: 750,000,000
Shares Outstanding: 44,177,973
Shares Outstanding Date: 10/17/2019
Shares Holder Count: 73
Shares Holder Date: 10/30/2018
Market Capitalization: $ 87,030,606.81
Key Executives: Craig Eagle - Dir.
Omar Gzouli - Dir.
Todd Falls - IR
Marshal Schictman - EVP
Mark Corrao - CFO
Lawrence Salvo - Dir.
Andrew Ro - CIO
Joseph Moscato Jr. - President
Terry Thompson - COO
Richard Purcell - SVP, R&D
Dr. James Anderson, Jr., MD - Dir.
Brian McGee - Dir.
Anthony Crisci - Chief Legal Officer
Mark Prioletti - Dir.
Dr. Jason Terrell, MD - CSO
Number of Employees: 112
Incorporation State: DE
Incorporation Country: USA
Incorporation Year: 1997
Auditor: Mazars LLP
Auditor Address: 215 St Jacques St.
Montreal, QC H2Y 1M6
Canada
Auditor Website: http://www.mazars.ca
IR Firm: N/A
Legal Counsel: Eckert Seamans Cherin & Mellott, LLC
Legal Counsel Address: 600 Grant Street
600 Grant Street
Pittsburgh, PA 15219
USA
Legal Counsel Website: N/A
Fiscal Year End: 7/31
Reporting Status: SEC Reporting
Bankrupt: No
Shell: No
Audit Status: Yes
ADR Ratio: N/A
Transfer Agent: Broadridge Financial Solutions, Inc.
TA Address: 51 Mercedes Way
Suite 1300
Philadelphia, PA 11717
USA
Depository Website: N/A
SHO Flag: N/A
3210 Flag: N/A
Short Volume: 652,897
Short Date: 09/13/2019
Closing MMID: 13
BFCMmid: 12
Tier ID: 10
Status: Active


Your Recent History
USOTC
GNBT
Generex Bi..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.